Junyou Wang

Junyou Wang

Auto-generated profile, based on publicly available information

Junyou Wang

East China University of Science and Technology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2021 in ACS Omega
Verified
Journal Article
Open access
RARizwan Ahmed
Rizwan Ahmed
MWMingwei Wang
Mingwei Wang
ZQZhiyao Qi
Zhiyao Qi
NHNoor Ul Ain Hira
Noor Ul Ain Hira
JJJiahui Jiang
Jiahui Jiang
XGXuhong Guo
Xuhong Guo
Few natural, biocompatible, and inexpensive emulsifiers are available because such emulsifiers must satisfy severe requirements, be produced synthetically rather than naturally, be nontoxic, and require minimal effort to produce. Therefore, the synthesis of food-grade and biocompatible nanoparticles as an alternative to surfactants has recently received attention in the industry. However, many previous efforts involved chemical modification of materials or the introduction of secondary cocomponents for emulsion formation. To achieve the goal of simple preparation, we consider here chitosan nanoparticles to prepare Pickering emulsions of food-grade oil through the control of pH, without further chemical modification or extra additives. A mild process can prepare nanoparticles from chitosan by simply increasing the pH from 3.0 to 6.0. The results showed that the average radius of chitosan at pH 6.0 was 170 nm, while large aggregates were formed at pH 6.5. These nanoparticles were utilized to prepare the Pickering emulsion. The average size of emulsion droplets decreased upon increasing the pH from 3.0 to 6.0. Moreover, Pickering emulsions at different oil fractions and nanoparticle concentrations were stable and showed a low creaming index for 45 days. The emulsions were stable against coalescence and flocculation and behaved rheologically as gel-like, shear-thinning fluids (G′ > G″). Pickering emulsion prevents the growth of the microorganism (Staphylococcus aureus) at different pH values and chitosan concentrations. These results demonstrate that chitosan nanoparticles could be a cost-effective and biocompatible emulsifier for the food or pharmaceutical industry for encapsulation and bioactive compounds, and Pickering emulsions have promising antibacterial effects for further applications.

21 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JWJiahua Wang
Jiahua Wang
MAManzar Abbas
Manzar Abbas
JWJunyou Wang
Junyou Wang
ESEvan Spruijt
Evan Spruijt
Coacervate droplets are promising protocell models because they sequester a wide range of guest molecules and may catalyze their conversion. However, it remains unclear how life’s building blocks, including peptides, could be synthesized from primitive precursor molecules inside such protocells. Here, we develop a redox-active protocell model formed by phase separation of prebiotically relevant ferricyanide (Fe(CN)63−) molecules and cationic peptides. Their assembly into coacervates can be regulated by redox chemistry and the coacervates act as oxidizing hubs for sequestered metabolites, like NAD(P)H and gluthathione. Interestingly, the oxidizing potential of Fe(CN)63− inside coacervates can be harnessed to drive the formation of new amide bonds between prebiotically relevant amino acids and α-amidothioacids. Aminoacylation is enhanced in Fe(CN)63−/peptide coacervates and selective for amino acids that interact less strongly with the coacervates. We finally use Fe(CN)63−-containing coacervates to spatially control assembly of fibrous networks inside and at the surface of coacervate protocells. These results provide an important step towards the prebiotically relevant integration of redox chemistry in primitive cell-like compartments.

5 November 2019 in Macromolecules
Verified
Journal Article
Closed access
JWJiahua Wang
Jiahua Wang
SSShengtong Sun
Shengtong Sun
BWBohang Wu
Bohang Wu
LHLei Hou
Lei Hou
PDPeng Ding
Peng Ding
JWJunyou Wang
Junyou Wang

7 November 2023 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
JWJiahua Wang
Jiahua Wang
MAManzar Abbas
Manzar Abbas
YHYu Huang
Yu Huang
JWJunyou Wang
Junyou Wang
MWMing-Liang Wang
Ming-Liang Wang
Proteinous drugs are highly promising therapeutics to treat various diseases. However, they suffer from limited circulation times and severe off-target side effects. Inspired by active membraneless organelles capable of dynamic recruitment and releasing of specific proteins, here, we present the design of coacervates as therapeutic protocells, made from small metabolites (anionic molecules) and simple arginine-rich peptides (cationic motif) through liquid-liquid phase separation. These complex coacervates demonstrate that their assembly and disassembly can be regulated by redox chemistry, which helps to control the release of the therapeutic protein. A model proteinous drugs, tissue plasminogen activator (tPA), can rapidly compartmentalize inside the complex coacervates, and the coacervates formed from peptides conjugated with arginine-glycine-aspartic acid (RGD) motif (a fibrinogen-derived peptide sequence), show selective binding to the thrombus site and thus enhance on-target efficacy of tPA. Furthermore, the burst release of tPA can be controlled by the redox-induced dissolution of the coacervates. Our proof-of-principle complex coacervate system provides insights into the sequestration and release of proteinous drugs from advanced drug delivery systems and represents a step toward the construction of synthetic therapeutic protocells for biomedical applications.

4 February 2019 in Macromolecules
Verified
Journal Article
Closed access
ZYZhenyu Yuan
Zhenyu Yuan
JWJie Wang
Jie Wang
YWYiming Wang
Yiming Wang
YZYujie Zhong
Yujie Zhong
XZXinsheng Zhang
Xinsheng Zhang
XGXuhong Guo
Xuhong Guo

10 March 2023 in Science Advances
Verified
Journal Article
Closed access
ZZZheng Zhang
Zheng Zhang
PDPeng Ding
Peng Ding
YMYichen Meng
Yichen Meng
TLTao Lin
Tao Lin
ZZZhanrong Zhang
Zhanrong Zhang
XZXuhui Zhou
Xuhui Zhou
Targeted transfection of siRNA to preosteoclasts features the potential of anti-osteoporosis, yet challenge arises from the development of satisfied delivery vehicles. Here, we design a rational core-shell nanoparticle (NP) composed of cationic and responsive core for controlled load and release of small interfering RNA (siRNA) and compatible polyethylene glycol shell modified with alendronate for enhanced circulation and bone-targeted delivery of siRNA. The designed NPs perform well on transfection of an active siRNA (siDcstamp) that interferes Dcstamp mRNA expression, leading to impeded preosteoclast fusion and bone resorption, as well as promoted osteogenesis. In vivo results corroborate the abundant siDcstamp accumulation on bone surfaces and the enhanced trabecular bone mass volume and microstructure in treating osteoporotic OVX mice by rebalancing bone resorption, formation, and vascularization. Our study validates the hypothesis that satisfied transfection of siRNA enables preserved preosteoclasts that regulate bone resorption and formation simultaneously as potential anabolic treatment for osteoporosis.